Logo image of COO

COOPER COS INC/THE (COO) Stock Fundamental Analysis

NASDAQ:COO - Nasdaq - US2166485019 - Common Stock - Currency: USD

73.02  +0.21 (+0.29%)

After market: 73.02 0 (0%)

Fundamental Rating

5

COO gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 187 industry peers in the Health Care Equipment & Supplies industry. COO scores excellent on profitability, but there are some minor concerns on its financial health. COO has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year COO was profitable.
In the past year COO had a positive cash flow from operations.
In the past 5 years COO has always been profitable.
Each year in the past 5 years COO had a positive operating cash flow.
COO Yearly Net Income VS EBIT VS OCF VS FCFCOO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

1.2 Ratios

COO has a better Return On Assets (3.34%) than 79.14% of its industry peers.
The Return On Equity of COO (5.00%) is better than 79.14% of its industry peers.
Looking at the Return On Invested Capital, with a value of 4.58%, COO is in the better half of the industry, outperforming 77.54% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for COO is below the industry average of 7.89%.
The 3 year average ROIC (3.86%) for COO is below the current ROIC(4.58%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.34%
ROE 5%
ROIC 4.58%
ROA(3y)3.02%
ROA(5y)8.65%
ROE(3y)4.71%
ROE(5y)12.56%
ROIC(3y)3.86%
ROIC(5y)3.93%
COO Yearly ROA, ROE, ROICCOO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

COO has a better Profit Margin (10.39%) than 85.03% of its industry peers.
In the last couple of years the Profit Margin of COO has declined.
COO has a better Operating Margin (19.00%) than 91.98% of its industry peers.
COO's Operating Margin has declined in the last couple of years.
With a decent Gross Margin value of 67.20%, COO is doing good in the industry, outperforming 73.26% of the companies in the same industry.
COO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 19%
PM (TTM) 10.39%
GM 67.2%
OM growth 3Y0.82%
OM growth 5Y-2.83%
PM growth 3Y-53.59%
PM growth 5Y-10.55%
GM growth 3Y-0.14%
GM growth 5Y0.13%
COO Yearly Profit, Operating, Gross MarginsCOO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80 100

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so COO is destroying value.
Compared to 1 year ago, COO has more shares outstanding
Compared to 5 years ago, COO has less shares outstanding
Compared to 1 year ago, COO has an improved debt to assets ratio.
COO Yearly Shares OutstandingCOO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
COO Yearly Total Debt VS Total AssetsCOO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

An Altman-Z score of 3.60 indicates that COO is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.60, COO is in the better half of the industry, outperforming 71.66% of the companies in the same industry.
COO has a debt to FCF ratio of 7.07. This is a slightly negative value and a sign of low solvency as COO would need 7.07 years to pay back of all of its debts.
COO has a Debt to FCF ratio of 7.07. This is in the better half of the industry: COO outperforms 77.54% of its industry peers.
A Debt/Equity ratio of 0.31 indicates that COO is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.31, COO is in line with its industry, outperforming 47.59% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 7.07
Altman-Z 3.6
ROIC/WACC0.56
WACC8.19%
COO Yearly LT Debt VS Equity VS FCFCOO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.3 Liquidity

A Current Ratio of 2.10 indicates that COO has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.10, COO is doing worse than 63.64% of the companies in the same industry.
A Quick Ratio of 1.23 indicates that COO should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.23, COO is doing worse than 71.66% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.1
Quick Ratio 1.23
COO Yearly Current Assets VS Current LiabilitesCOO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 13.95% over the past year.
Measured over the past 5 years, COO shows a small growth in Earnings Per Share. The EPS has been growing by 3.69% on average per year.
COO shows a small growth in Revenue. In the last year, the Revenue has grown by 6.88%.
The Revenue has been growing slightly by 7.98% on average over the past years.
EPS 1Y (TTM)13.95%
EPS 3Y3.78%
EPS 5Y3.69%
EPS Q2Q%12.94%
Revenue 1Y (TTM)6.88%
Revenue growth 3Y10.05%
Revenue growth 5Y7.98%
Sales Q2Q%6.33%

3.2 Future

Based on estimates for the next years, COO will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.51% on average per year.
The Revenue is expected to grow by 5.84% on average over the next years.
EPS Next Y11.1%
EPS Next 2Y9.77%
EPS Next 3Y9.8%
EPS Next 5Y8.51%
Revenue Next Year5.5%
Revenue Next 2Y5.97%
Revenue Next 3Y6.01%
Revenue Next 5Y5.84%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
COO Yearly Revenue VS EstimatesCOO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B 5B
COO Yearly EPS VS EstimatesCOO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3 4 5

5

4. Valuation

4.1 Price/Earnings Ratio

COO is valuated rather expensively with a Price/Earnings ratio of 18.82.
Based on the Price/Earnings ratio, COO is valued cheaply inside the industry as 81.82% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of COO to the average of the S&P500 Index (27.28), we can say COO is valued slightly cheaper.
A Price/Forward Earnings ratio of 16.38 indicates a correct valuation of COO.
81.82% of the companies in the same industry are more expensive than COO, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of COO to the average of the S&P500 Index (21.76), we can say COO is valued slightly cheaper.
Industry RankSector Rank
PE 18.82
Fwd PE 16.38
COO Price Earnings VS Forward Price EarningsCOO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

79.14% of the companies in the same industry are more expensive than COO, based on the Enterprise Value to EBITDA ratio.
COO's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. COO is cheaper than 78.61% of the companies in the same industry.
Industry RankSector Rank
P/FCF 39.91
EV/EBITDA 15.17
COO Per share dataCOO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of COO may justify a higher PE ratio.
PEG (NY)1.7
PEG (5Y)5.11
EPS Next 2Y9.77%
EPS Next 3Y9.8%

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.02%, COO is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 1.82, COO pays a better dividend. On top of this COO pays more dividend than 89.84% of the companies listed in the same industry.
With a Dividend Yield of 0.02, COO pays less dividend than the S&P500 average, which is at 2.42.
Industry RankSector Rank
Dividend Yield 0.02%

5.2 History

COO has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
COO Yearly Dividends per shareCOO Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 0.01 0.01 0.02

5.3 Sustainability

DP0%
EPS Next 2Y9.77%
EPS Next 3Y9.8%
COO Yearly Income VS Free CF VS DividendCOO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

COOPER COS INC/THE

NASDAQ:COO (7/2/2025, 8:27:32 PM)

After market: 73.02 0 (0%)

73.02

+0.21 (+0.29%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-29 2025-05-29/amc
Earnings (Next)08-26 2025-08-26/amc
Inst Owners101.9%
Inst Owner Change0.75%
Ins Owners0.59%
Ins Owner Change12.84%
Market Cap14.60B
Analysts78.33
Price Target97.4 (33.39%)
Short Float %2.96%
Short Ratio2.31
Dividend
Industry RankSector Rank
Dividend Yield 0.02%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.13%
Min EPS beat(2)-0.21%
Max EPS beat(2)2.46%
EPS beat(4)3
Avg EPS beat(4)2.45%
Min EPS beat(4)-0.21%
Max EPS beat(4)4.45%
EPS beat(8)5
Avg EPS beat(8)2.14%
EPS beat(12)7
Avg EPS beat(12)0.82%
EPS beat(16)9
Avg EPS beat(16)0.35%
Revenue beat(2)0
Avg Revenue beat(2)-1.31%
Min Revenue beat(2)-2.35%
Max Revenue beat(2)-0.27%
Revenue beat(4)0
Avg Revenue beat(4)-1.21%
Min Revenue beat(4)-2.35%
Max Revenue beat(4)-0.27%
Revenue beat(8)2
Avg Revenue beat(8)-0.51%
Revenue beat(12)6
Avg Revenue beat(12)-0.1%
Revenue beat(16)10
Avg Revenue beat(16)0.5%
PT rev (1m)-10.44%
PT rev (3m)-11.88%
EPS NQ rev (1m)1.15%
EPS NQ rev (3m)1.15%
EPS NY rev (1m)2.1%
EPS NY rev (3m)2.02%
Revenue NQ rev (1m)-0.56%
Revenue NQ rev (3m)-0.56%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)-0.05%
Valuation
Industry RankSector Rank
PE 18.82
Fwd PE 16.38
P/S 3.66
P/FCF 39.91
P/OCF 19.15
P/B 1.76
P/tB 5.35
EV/EBITDA 15.17
EPS(TTM)3.88
EY5.31%
EPS(NY)4.46
Fwd EY6.11%
FCF(TTM)1.83
FCFY2.51%
OCF(TTM)3.81
OCFY5.22%
SpS19.94
BVpS41.44
TBVpS13.65
PEG (NY)1.7
PEG (5Y)5.11
Profitability
Industry RankSector Rank
ROA 3.34%
ROE 5%
ROCE 6.65%
ROIC 4.58%
ROICexc 4.63%
ROICexgc 9.08%
OM 19%
PM (TTM) 10.39%
GM 67.2%
FCFM 9.17%
ROA(3y)3.02%
ROA(5y)8.65%
ROE(3y)4.71%
ROE(5y)12.56%
ROIC(3y)3.86%
ROIC(5y)3.93%
ROICexc(3y)3.91%
ROICexc(5y)3.98%
ROICexgc(3y)7.96%
ROICexgc(5y)8.62%
ROCE(3y)5.65%
ROCE(5y)5.73%
ROICexcg growth 3Y7.03%
ROICexcg growth 5Y-21.56%
ROICexc growth 3Y2.56%
ROICexc growth 5Y-10.24%
OM growth 3Y0.82%
OM growth 5Y-2.83%
PM growth 3Y-53.59%
PM growth 5Y-10.55%
GM growth 3Y-0.14%
GM growth 5Y0.13%
F-Score9
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 7.07
Debt/EBITDA 2.3
Cap/Depr 109.05%
Cap/Sales 9.94%
Interest Coverage 250
Cash Conversion 67.99%
Profit Quality 88.34%
Current Ratio 2.1
Quick Ratio 1.23
Altman-Z 3.6
F-Score9
WACC8.19%
ROIC/WACC0.56
Cap/Depr(3y)96.32%
Cap/Depr(5y)93.28%
Cap/Sales(3y)9.68%
Cap/Sales(5y)9.83%
Profit Quality(3y)87.75%
Profit Quality(5y)70.99%
High Growth Momentum
Growth
EPS 1Y (TTM)13.95%
EPS 3Y3.78%
EPS 5Y3.69%
EPS Q2Q%12.94%
EPS Next Y11.1%
EPS Next 2Y9.77%
EPS Next 3Y9.8%
EPS Next 5Y8.51%
Revenue 1Y (TTM)6.88%
Revenue growth 3Y10.05%
Revenue growth 5Y7.98%
Sales Q2Q%6.33%
Revenue Next Year5.5%
Revenue Next 2Y5.97%
Revenue Next 3Y6.01%
Revenue Next 5Y5.84%
EBIT growth 1Y25.84%
EBIT growth 3Y10.95%
EBIT growth 5Y4.93%
EBIT Next Year27.65%
EBIT Next 3Y15.28%
EBIT Next 5Y12.64%
FCF growth 1Y-5.53%
FCF growth 3Y-18.09%
FCF growth 5Y-7.31%
OCF growth 1Y11.23%
OCF growth 3Y-1.34%
OCF growth 5Y-0.11%